Ionotropic glutamate receptors (iGluRs)4 are the major mediators of excitatory neurotransmission in the brain and play important roles both in neuronal development and synaptic function (1). They are tetrameric protein complexes (2, 3) in which each subunit is composed of (i) an extracellular aminoterminal domain, (ii) a ligand binding domain (LBD), sharing sequence homology to bacterial periplasmic binding proteins, (iii) a membrane-associated domain with the transmembrane helices M1-M4 that forms the ion pore, and (iv) an intracellular carboxyl-terminal domain (4).The family of iGluRs is divided into the subclasses of AMPA, kainate, and NMDA receptors that differ, among other things, in their ligand specificities (1). Despite the pharmacological differences, crystal structures have been obtained for LBDs of subunits from all three subclasses of iGluRs (5-9) and have revealed a conserved clam shell-like architecture of two lobes (D1 and D2) around a central cleft that harbors the ligand binding site. Lobe D1 is formed from residues preceding the first transmembrane domain (M1) and the C-terminal residues of the extracellular loop between transmembrane domains 3 and 4, whereas the N-terminal part of this loop forms lobe D2.LBD structures in complex with different ligands (10 -12) have shed light on the molecular mechanism of ligand binding and, in the absence of structural information on the transmembrane domain, have led to the formulation of hypotheses on how agonist binding may be coupled to channel gating. Agonists differ from antagonists in that they promote closure of the LBD clam shell through rotation of lobe D2 toward D1. In a largely mechanical model of receptor activation (11), this motion is thought to generate conformational strain within the tetrameric receptor complex that transduces to the membrane regions and, eventually, causes channel opening. Several studies in AMPA and kainate iGluRs (6, 7, 11) relating structure to agonist efficacy show that the degree of domain closure induced by different agonists correlates with their functional activity. Interestingly, there is evidence that the glycine binding domain of the NR1 subunit of the NMDA receptor does not exhibit a similar correlation between domain closure and agonist efficacy (8,12). Recent structure-function data show that engineering sterical restrictions within the glutamate-binding pocket of the NR2B subunit of the NMDA receptor is correlated to the degree of agonist efficacy (13), implicating that the action of glutamate and glycine on the NR2 and NR1 subunits, respectively, may induce different structural mechanisms underlying agonist efficacy.However, although crystallographic data have uncovered the difference between agonist-and antagonist-bound LBD struc-